During the past decade, Illinois eye and ear infirmary conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois eye and ear infirmary" #1 sponsor was "University of Illinois at Chicago" with 3 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Sandeep Jain, MD" with 2 trials sponsored, "Joseph B. Ciolino, MD" with 1 trials sponsored and "Quark Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois eye and ear infirmary" #1 collaborator was "Illinois Society for the Prevention of Blindness" with 1 trials as a collaborator, "Ocugen" with 1 trials as a collaborator, "United States Department of Defense" with 1 trials as a collaborator and "VitreoRetinal Surgery Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Illinois eye and ear infirmary" are "Dry Eye" (3 trials), "Geographic Atrophy" (2 trials), "Macular Degeneration, Age-Related" (2 trials), "Age Related Macular Degeneration" (1 trials) and "Keratoconus" (1 trials). Many other conditions were trialed in "Illinois eye and ear infirmary" in a lesser frequency.

Most popular intervention types in "Illinois eye and ear infirmary" are "Drug" (8 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Galegenimab" (2 trials), "Brimonidine 0.075%" (1 trials), "Brimonidine 0.15%" (1 trials) and "Corneal gas permeable lens" (1 trials). Other intervention names were less common.

The vast majority of trials in "Illinois eye and ear infirmary" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Illinois eye and ear infirmary". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Illinois eye and ear infirmary, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois eye and ear infirmary, 4 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".